• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Rx data: A setback for doctors in Maine

Article

Following the lead of a 2007 ruling in New Hampshire, a federal judge in Maine has overturned a law that would have restricted access to information on doctors' prescribing habits.

Following the lead of a 2007 ruling in New Hampshire, a federal judge in Maine has overturned a law that would have restricted access to information on doctors' prescribing habits. The legislation was aimed at stopping healthcare information companies from collecting, analyzing, and selling data about doctors' prescribing patterns to drug companies. The successful challenge was brought by three data mining companies: IMS Health, Wolters Kluwer Health, and Verispan. "It's vital that provider-level prescription information remain accessible," said Randy Frankel, IMS vice president for external affairs, "because it has proven value in efforts to monitor safety and manage quality, treatment variability, and healthcare costs."

An appeal in the Maine case is expected. Meanwhile, a similar case in another New England state, Vermont, is pending.

Related Videos
© drsampsondavis.com
© drsampsondavis.com
© drsampsondavis.com
© drsampsondavis.com